125 related articles for article (PubMed ID: 2137365)
1. The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.
Geisinger KR; Berens ME; Duckett Y; Morgan TM; Kute TE; Welander CE
Cancer; 1990 Mar; 65(5):1055-61. PubMed ID: 2137365
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
[TBL] [Abstract][Full Text] [Related]
3. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
Osborne CK; Von Hoff DD; Mullins K
Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413
[TBL] [Abstract][Full Text] [Related]
4. [Hormone dependence of malignant ovarian tumors--an in vitro model].
Schieder K; Bieglmayer C; Kölbl H
Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
[TBL] [Abstract][Full Text] [Related]
5. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Sevelda P
Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
[TBL] [Abstract][Full Text] [Related]
6. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
[TBL] [Abstract][Full Text] [Related]
7. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.
Gundersen S; Kvinnsland S; Lundgren S; Klepp O; Lund E; Børmer O; Høst H
Breast Cancer Res Treat; 1990 Nov; 17(1):45-50. PubMed ID: 2151369
[TBL] [Abstract][Full Text] [Related]
8. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
Beltrán M; Alonso MC; Ojeda MB; Izquierdo A; Ferrer J; Picó C; Anglada L; Catalán G; Batiste-Alentorn E; Tusquets I
Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
[TBL] [Abstract][Full Text] [Related]
10. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
11. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate.
Shaikh NA; Owen AM; Ghilchik MW; Braunsberg H
Int J Cancer; 1989 Apr; 43(4):733-6. PubMed ID: 2522913
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo.
Kangas L; Grönroos M
J Steroid Biochem; 1990 Jun; 36(3):253-7. PubMed ID: 2142248
[TBL] [Abstract][Full Text] [Related]
14. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
15. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L
Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665
[TBL] [Abstract][Full Text] [Related]
16. [Significance of the colony formation test in ovarian carcinoma].
Runge HM; Bücke W; Neumann HA
Onkologie; 1984 May; 7 Suppl 2():66-73. PubMed ID: 6235468
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of lonidamine alone or combined with tamoxifen or medroxyprogesterone acetate in breast cancer cells.
Sica G; Lama G; Iacopino F; Angelucći C; Della Cuna GR; Marchetti P
Anticancer Res; 1991; 11(6):2099-102. PubMed ID: 1776846
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
Mouridsen HT; Palshof T; Rose C
Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913
[TBL] [Abstract][Full Text] [Related]
19. Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma.
Riippa P; Kauppila A; Sundström H; Vihko R
Anticancer Res; 1984; 4(3):109-12. PubMed ID: 6235770
[TBL] [Abstract][Full Text] [Related]
20. Direct antiproliferative effect of triptorelin on human breast cancer cells.
Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G
Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
